- Location
Memorial Sloan Kettering Cancer Center
"-
IBM Faces a Puzzle That Might Give Even The World's Greatest Detective Pause
Jan 13, 2014IBM faces a puzzle that might give even the world's greatest detective pause: How to grow its "Jeopardy"-conquering Watson supercomputer into a $10-billion business within a decade. The company hopes to boost Watson's profit-making ...
Tags: IBM, Watson, supercomputer, investment
-
Several Ways to Win The Predictions Game
Jan 13, 2014One way to win the predictions game is to make a lot of guesses and remember just the winners. Here at IEEE Spectrum, we play a harder game. We told you what to expect in 2013, and now we are 'fessing up to our misses, as well as bragging ...
Tags: Postmortem, IEEE Spectrum
-
IBM Is Spending $1 Billion to Give Watson Its Own New York City-Based Business Division
Jan 10, 2014IBM is spending $1 billion to give Watson its own New York City–based business division as it seeks commercial applications for its Jeopardy-winning supercomputer in healthcare and other fields. But will medical companies truly find a ...
Tags: IBM, Computer Products
-
Sutro Biopharma Has Entered Into a Collaboration Agreement
Jan 8, 2014Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
-
Ludwig Center at Johns Hopkins to Receive $90 Million in New Funding
Jan 7, 2014Ludwig Center at Johns Hopkins to receive $90 million in new funding Scientists at the Johns Hopkins Kimmel Cancer Center will receive $90 million in new funding as part of a $540 million gift from Ludwig Cancer Research, on behalf of its ...
Tags: Johns Hopkins Kimmel Cancer Center, funding, Ludwig Cancer Research
-
Gene Therapy Might Be a Powerful Weapon Against Leukemia and Other Blood Cancers
Dec 26, 2013Preliminary research shows that gene therapy might one day be a powerful weapon against leukemia and other blood cancers. The experimental treatment coaxed certain blood cells into targeting and destroying cancer cells, according to ...
Tags: gene therapy, leukemia, blood cancer
-
Esteya for Treating Skin Cancer in Major Us Center Has Been Installed by Nucletron
Dec 17, 2013Nucletron has announced that the first Esteya electronic brachytherapy system in the US has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer ...
Tags: Nucletron, Skin Cancer
-
Foundationone Heme Has Been Launched by Foundation Medicine
Dec 11, 2013Foundation Medicine, a molecular information company, has announced the launch of its second clinical product, FoundationOne Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many ...
-
Surrealist-Themed Holiday Pop-up Shop Is Unveiled by FIT Students
Nov 26, 2013A Surrealist-themed holiday pop-up shop designed, installed, and merchandised by students in the Visual Presentation and Exhibit Design program with items for sale from The Society of Memorial Sloan-Kettering Cancer Center Thrift Shop ...
Tags: Pop-up Shop, FIT Students
-
Society of Memorial Sloan-Kettering Cancer Center Thrift Shop to open at FIT's Pomerantz
Nov 14, 2013A Surrealist-themed holiday pop-up shop designed, installed, and merchandised by students in the Visual Presentation and Exhibit Design program with items for sale from The Society of Memorial Sloan-Kettering Cancer Center Thrift Shop will ...
Tags: pop-up shop, Holiday Season
-
Most Staff at Sloan Kettering Cancer Center Have Been Vaccinated Against Influenza
Nov 12, 2013Most staff at Memorial Sloan Kettering Cancer Center in New York have been vaccinated against influenza, hospital officials say. The results come about nine weeks into a campaign to have employees vaccinated against influenza, ...
Tags: Sloan Kettering, staff, vaccinated, influenza
-
Pivotal Clinical Validation Study for 4kscore Test Were Commenced by OPKO
Nov 6, 2013OPKO Health, a multinational pharmaceutical and diagnostics company, has commenced a pivotal, multi-center clinical validation study for the company’s 4Kscore test for the prediction of prostate cancer prior to prostate biopsy. The ...
Tags: OPKO Health, Medicine
-
Affymetrix Launched OncoScan FFPE Assay Kit at Chicago
Aug 6, 2013Affymetrix has launched a whole-genome copy number assay for highly degraded FFPE solid tumor samples, called OncoScan FFPE assay kit, at Chicago. The new OncoScan FFPE assay kit with its unique molecular inversion probe (MIP) technology ...
Tags: Affymetr, FFPE solid tumor samples
-
The Biggest Charity "Thons" Were Flat or Slightly Down in 2012
Jun 24, 2013While the biggest charity "thons" were flat or slightly down in 2012, most dedicated to cycling saw healthy increases.? "When we look at the results, the really strong results are in the cycling area," said David Hessekiel, president of ...
Tags: Transportation, bike
-
Actinium Pharmaceuticals Has Received Notice of Patent Allowance for an Application
May 16, 2013Biopharmaceutical company Actinium Pharmaceuticals has received notice of patent allowance for an application covering the treatment of metastatic solid cancers with alpha emitting isotopes. The patent application 'Alpha Emitting ...
Tags: Actinium, Cancer Treatment